Hi!欢迎来到ChemicalBook
登录
注册
热线电话:400-158-6606
行业精选
我的ChemicalBook
发布产品
产品管理
发布供应信息
黄金产品设置
大货产品设置
直通车产品设置
∨
发布供应信息
产品
求购信息
供应信息
化工站点
结构式搜索
采购清单
网站主页
MK-7246
化合物 MK-7246
化合物 MK-7246|TQ0051|TargetMol
价格
¥
6910
¥
1550
¥
12200
包装
5mg
1mg
10mg
最小起订量
1mg
发货地
上海
更新日期
2024-09-29
QQ交谈
微信洽谈
产品详情
中文名称:
化合物 MK-7246
英文名称:
MK-7246
CAS:
1218918-62-7
品牌:
TargetMol
产地:
美国
保存条件:
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
产品类别:
抑制剂
货号:
TQ0051
2024-09-29
化合物 MK-7246
MK-7246
5mg/6910RMB;1mg/1550RMB;10mg/12200RMB
6910
TargetMol
美国
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
抑制剂
Product Introduction
Bioactivity
名称
MK-7246
描述
MK-7246 is a potent and specific CRTH2 antagonist (Ki: 2.5 nM).
激酶实验
The binding kinetics of [3H]MK-7246 (specific activity, 41 Ci/mmol) at human CRTH2 is characterized using recombinant HEK293E cell membranes. The radioligand binding experimental condition for CRTH2 as follows: the incubation mixture contains 10 mM MgCl2 instead of MnCl2, 10 nM [3H]MK-7246, and 1.25 μg of membrane protein. Total binding represents 10% of the radioligand adds to the incubation media, and specific binding at equilibrium corresponded to 85 to 95% of the total binding. The membranes are first incubated with [3H]MK-7246 for 120 min in the absence (total binding) or presence (nonspecific binding) of 10 μM MK-7246. To one series of total binding incubation tubes, 10 μM MK-7246 or 100 μM PGD2 is added to initiate dissociation of the radioligand from the receptor, and the reaction is left to proceed for up to 300 min. The samples are then harvested and processed as detailed above. The association and dissociation kinetic data analysis is done by nonlinear regression curve-fitting using Prism software to determine the observed on rate (Kobs) and dissociation rate (koff) constants, and t1/2 of on and off rates [1].
动物实验
Intratracheal Budesonide is dosed 1 h prior to and 23 h post the A. alternate intratracheal dose while oral Budesonide (3 mg/kg) is administered 2 h before and 22 h post the A. alternata extract instillation. An intratracheally dosed Budesonide is prepared. MK-7246 (3, 10, 30 and 100 mg/kg) is administered orally 1 h before and 23 h post an A. alternata extract instillation in order to examine the effect of the CRTH2 antagonist on A. alternata elicited pulmonary inflammatory responses. Budesonide dosed orally is used as a positive control in both experiments. The animals are lightly anesthetized with 3% Isoflurane (supplemented with 100% oxygen), either 2 h following oral dosing or 1 h following intratracheal dosing. The animals are also secured on a rodent work stand to facilitate the localization of the larynx and tracheal openings. The micro sprayer needle is inserted into the trachea and 0.1 mL of 10,000 μg/mL (total of 1000 μg) A. alternata extract is administered using a micro sprayer. The animals are observed until they recover from anesthesia and then return to their cages and allow food and water ad libitum [2].
体外活性
MK-7246 competes for [3H]PGD2 specific binding to cell membranes expressing recombinant human CRTH2 with high-affinity (Ki, 2.5 nM). MK-7246 displays relatively high selectivity for CRTH2 with an affinity 149-fold lower for the DP receptor (Ki, 373±96 nM) and ≥1500-fold lower for the other prostanoid receptors (Ki, 7668±2169 nM for EP2, 3804±1290 nM for TP). MK-7246 is also tested in a panel of 157 enzyme and receptor assays at concentrations up to 100 μM and small but significant activity is detected only on phosphodiesterase 1 (PDE1, IC50=33.2 μM) and MAPK3 (ERK1, IC50=49.4 μM) [1].
体内活性
Whether the inhibition of a clinically-relevant mechanism of allergic lung inflammation such as CRTH2 will lead to a suppression of inflammatory responses is investigated in A. alternata challenged Brown Norway rats (n=8 per group). CRTH2 inhibitor MK-7246 is orally administered 1 h before and 23 h post-intratracheal instillation of the A. alternata. MK-7246 produces a dose-dependent decrease in the number of eosinophils with a maximal inhibition of 74±5% in the 100 mg/kg group (P<0.05), IL-5 (80±12%) and IL-13 (76±14%) cytokines levels (P<0.05) [2].
存储条件
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度
DMSO : 245 mg/mL (588.27 mM)
关键字
MK7246 | MK 7246 | MK-7246
相关产品
Benzyl nicotinate | CRTh2 antagonist 2 | Ramatroban | CAY10595 | Questiomycin A | TUG-1375 | NF-56-EJ40 | Monomethyl fumarate | 3-Hydroxyoctanoic Acid | Fezagepras sodium | Timapiprant | Vincamine
关键字:
MK-7246|TargetMol
公司简介
TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿,致力于为全球生化领域科学家的研究提供专业的产品和服务。TargetMol?品牌的客户群分布于40多个国家和地区,已发展成为全球知名的化合物库和小分子化合物研究供应商。 TargetMol?可提供160多种满足不同需求的化合物库,以及多种类型的生化试剂产品,包括12000多种抑制剂、16000多种天然产物和各类多肽、抗体、生命科学试剂盒等,此外,我们还建设有CADD(计算机辅助药物设计)研究中心、药理实验室、药化合成平台三大技术中心,全方位满足客户的定制需求。 凭借我们优质的产品和服务、快速高效的全球供应链和专业的技术支持,我们将有效帮助您缩短研发周期,取得更成功的结果。
成立日期
2013-04-18
(12年)
注册资本
566.265100万人民币
员工人数
100-500人
年营业额
¥ 1亿以上
主营行业
天然产物,生化试剂,分子生物学,分子砌块,生物技术服务
经营模式
贸易,工厂,试剂,定制,服务
TargetMol中国(陶术生物)
VIP
3年
公司成立:
12年
注册资本:
566.265100万人民币
企业类型:
有限责任公司(自然人投资或控股)
主营产品:
小分子抑制剂、药物筛选化合物库、药物筛选等
公司地址:
静安区江场三路238号8楼
进入店铺
询盘
店内推荐
化合物 Alimemazine|T10281|TargetMol
¥10600
达昔单抗|T73689|TargetMol
¥997
化合物 2’,3’-Anhydroadenosine|TNU0418|TargetMol
询价
化合物 MK-7246|TQ0051|TargetMol相关厂家报价
产品名称
价格
公司名称
报价日期
MK-4882
询价
VIP
5年
陕西缔都医药化工有限公司
2024-09-24
MK-1775
询价
VIP
6年
麻城市进鑫生物科技有限公司
2024-09-27
MK-886;
询价
VIP
3年
湖北诺迪纳生物技术有限公司
2024-09-26
内容声明:
以上所展示的信息由商家自行提供,内容的真实性、准确性和合法性由发布商家负责。 商家发布价格指该商品的参考价格,并非原价,该价格可能随着市场变化,或是由于您购买数量不同或所选规格不同而发生变化。最终成交价格,请咨询商家,以实际成交价格为准。请意识到互联网交易中的风险是客观存在的
主页
|
企业会员服务
|
广告业务
|
联系我们
|
旧版入口
|
中文MSDS
|
CAS Index
|
常用化学品CAS列表
|
化工产品目录
|
新产品列表
|
投诉中心
Copyright © 2008 ChemicalBook
京ICP备07040585号
京公海网安备110108000080号 All rights reserved.
400-158-6606
TargetMol中国(陶术生物)
联系人:
邵小姐
电话:
手机:
4008200310
邮箱:
marketing@tsbiochem.com
联系商家时请提及chemicalbook,有助于交易顺利完成!
产品咨询